Investor Alert

New York Markets After Hours

Gilead Sciences Inc.



After Hours

 --Real time quotes

May 17, 2022, 5:32 p.m.





+0.07 +0.11%


Volume 324,016

Real time quotes


Today's close

$ 62.24

$ 63.18


+0.94 +1.51%

Day low

Day high




52 week low

52 week high




Annual Financials for Gilead Sciences Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries 4.64B5.46B5.36B89M6.2B
Depreciation, Depletion & Amortization 1.29B1.43B1.4B1.48B2.05B
Depreciation and Depletion 233M226M255M288M329M
Amortization of Intangible Assets 1.05B1.2B1.15B1.19B1.72B
Deferred Taxes & Investment Tax Credit (82M)289M(2.1B)(214M)(116M)
Deferred Taxes (82M)289M(2.1B)(214M)(116M)
Investment Tax Credit -----
Other Funds 942M2.16B5.27B8.45B2.76B
Funds from Operations 6.79B9.34B9.94B9.81B10.9B
Extraordinaries -----
Changes in Working Capital 5.11B(939M)(798M)(1.64B)489M
Receivables 754M480M(218M)(1.17B)313M
Accounts Payable (430M)(39M)(61M)80M(118M)
Other Assets/Liabilities 358M903M(307M)(214M)(42M)
Net Operating Cash Flow 11.9B8.4B9.14B8.17B11.38B

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures (590M)(924M)(825M)(650M)(579M)
Capital Expenditures (Fixed Assets) (590M)(924M)(825M)(650M)(579M)
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions (10.43B)--(25.74B)(1.4B)
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments (5.05B)15.28B(2.31B)11.95B(987M)
Purchase of Investments (23.31B)(10.58B)(32.23B)(20.77B)(3.9B)
Sale/Maturity of Investments 18.26B25.86B29.92B32.72B2.91B
Other Uses --(4.69B)(171M)(163M)
Other Sources -----
Net Investing Cash Flow (16.07B)14.36B(7.82B)(14.62B)(3.13B)

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total (2.73B)(2.97B)(3.22B)(3.45B)(3.61B)
Common Dividends (2.73B)(2.97B)(3.22B)(3.45B)(3.61B)
Preferred Dividends -----
Change in Capital Stock (720M)(2.61B)(1.54B)(1.33B)(377M)
Repurchase of Common & Preferred Stk. (954M)(2.9B)(1.75B)(1.58B)(546M)
Sale of Common & Preferred Stock 234M289M209M256M169M
Proceeds from Stock Options 234M289M209M256M169M
Other Proceeds from Sale of Stock -----
Issuance/Reduction of Debt, Net 7.17B(6.25B)(2.75B)5.68B(4.75B)
Change in Current Debt -----
Change in Long-Term Debt 7.17B(6.25B)(2.75B)5.68B-
Issuance of Long-Term Debt 8.99B--8.18B-
Reduction in Long-Term Debt (1.81B)(6.25B)(2.75B)(2.5B)(4.75B)
Other Funds (330M)(486M)(122M)(138M)(145M)
Other Uses (330M)(486M)(122M)(138M)(145M)
Other Sources -----
Net Financing Cash Flow 3.39B(12.32B)(7.63B)770M(8.88B)
Exchange Rate Effect 137M(85M)(2M)43M(35M)
Miscellaneous Funds -----
Net Change in Cash (641M)10.35B(6.31B)(5.63B)(659M)
Free Cash Flow 11.31B7.48B8.32B7.52B10.81B
Link to MarketWatch's Slice.